Navigation Links
Arpida Announces Agenda Items for Shareholders Meeting
Date:4/15/2008

REINACH, Switzerland, April 15 /PRNewswire-FirstCall/ -- Arpida Ltd. (SWX: ARPN) today published the agenda for the Annual General Meeting of Shareholders, to be held in Basel on 7 May 2008. The invitation appears today in several Swiss media and will be sent to all registered Arpida shareholders. The agenda is available on the website http://www.arpida.com.

Apart from the yearly recurring agenda items, Arpida's Board of Directors will put two additional proposals to the shareholders.

The first additional agenda item relates to the proposed appointment of Elmar Schnee to the Board of Directors.

Elmar Schnee is a highly experienced Pharma executive who has gathered a wealth of international experience at several large and small pharmaceutical companies. He is currently President of Merck Serono S.A. and Regular Member of the Executive Board and General Partner of Merck KGaA, with responsibility for the Pharmaceuticals business sector. Mr Schnee is a Swiss national.

The terms of three current Arpida Board members expire in the AGM of 7 May 2008 and all three will stand for re-election. Professor Nam-Hai Chua, a Board member since 2004, has resigned from the Board.

The second additional proposal is aimed at increasing Arpida's flexibility in terms of potential financing instruments. In the past, Arpida's funds have primarily been provided by equity investors through the issue of shares. Going forward, Arpida may consider alternative sources of funding such as, for instance, convertible bonds.

In order to create the possibility to issue such instruments, the Company will ask its shareholders to make the necessary changes to its Articles of Association. If the shareholders' meeting approves these changes, Arpida will have the possibility to issue a total of no more than 3.2 million shares (15% of the currently outstanding share capital), either via a straight equity issue (
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Arpida Submits New Drug Application for Intravenous Iclaprim for Treatment of Skin Infections
2. Arpida Announces Full Year 2007 Financial Results
3. Arpida Provides Update on Progress of New Drug Application for Intravenous Iclaprim
4. Arpida Reports Progress in Pivotal Phase III Trial With TLT Treatment in Onychomycosis
5. Arpida Receives Green Light From US FDA for Phase II Efficacy Trial With Oral Iclaprim
6. Arpida-Supported CME Symposium Available Online
7. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
8. Arpida Presents Preclinical Data on AR-2474 at ICAAC
9. Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
10. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
11. Arpida Interim Results for six Months to 30 June 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...investment bank KTA Capital,s client Neuren Pharma...onvertible note private placement with a U.S. inst...nged by KTA Capital as Neuren,s exclusive placemen...w York (PRWEB) November 23, 2009 -- The independen...;KTA Capital") has announced that its client ...
(Date:11/24/2009)...io, Nov. 24 Dow AgroScie...sets of Hyland Seeds, a division of Thompsons Limi...eeds will further expand Dow AgroSciences, current...roduction of SmartStax(TM) in 2010 and Dow A... corn in 2012. The transactional close is expected...
(Date:11/24/2009)...wswire-FirstCall/ -- Sigma-Aldrich Corporation (Na... conference on Tuesday, December 1st at 1:45 PM GM...y listen via live audio broadcast over the Interne... ldrich.com/ . Users can click the "Webcast" ico...ch: Sigma-Aldrich is a leading Life Science and ...
(Date:11/24/2009)... Iceland, November 24 de...d the approval of all of its,"first day" motions b...laware,(the "Bankruptcy Court"). deCODE last week ...r 11 of the United States Bankruptcy Code with the... the Bankruptcy Court allow the company to continu...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...rs of experience as a leader in medical device tes...estlabs.com ) is offering free microbial identifi... lab tests, to eligible attendees visiting the Mic...ruary. , , The free offers highlight Microtest,s...ervices - and problem solving approach - that comb...
...Nasdaq: RGEN ) announced today that the Company ...erlihy, Ph.D., will present at the BIO CEO and Inv...11:30 a.m. EST at the Waldorf-Astoria Hotel, 301 P...t of the presentation will be available via Replig...hived for 30 days following the presentation. , ,...
...first clinically proven natural stimulator of grow...unity,s acceptance as a more desirable "first step...classified as a natural food supplement, Secretrop...physician due to its clinically proven ability to ...growth hormone. This reproducible response of Se...
Other Biology Technology:Microtest Labs Offers Free Microbial Identification Testing, Free Shipping on Other Tests, to MD&M West Attendees 2Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST 2Secretropin(R) - Effective, Preferable, Affordable as an Alternative to Injectable Growth Hormone - Gains Momentum 2
(Date:11/24/2009)...College of Medical Toxicology (ACMT) have signed a...he Journal of Medical Toxicology (JMT), the offi... It was previously published by the University of...Toxicology , an international, peer-reviewed journ...tice of medical toxicology. The quarterly journal...
(Date:11/24/2009)...4, 2009) New research on bacterial communities th... predictable temporal patterns, suggesting that sc...r monitoring climate change in the polar regions. ... of the National Academy of Sciences Early Editio...ers shifted synchronously over time, correlating w...
(Date:11/23/2009)...mber 23, 2009 Applied mathematicians dissected th...ia ), a characteristic long leaf with a saddle-lik...the edges. The simple cause of the lily,s fan-like...ring differential growthwas revealed by using an e..., Haiyi Liang, a postdoctoral student at Harvard...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2The cause behind the characteristic shape of a long leaf revealed 2Strong Social Connections Needed for Biotech to Grow in Los Angeles 14079 1Strong Social Connections Needed for Biotech to Grow in Los Angeles 14079 2Learn Your Way to Success 57316 1Learn Your Way to Success 57316 2Learn Your Way to Success 57316 3Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz Lamivudine and Tenofovir Disoproxil Fumarate Tablets 57314 1Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz Lamivudine and Tenofovir Disoproxil Fumarate Tablets 57314 2
...al team that includes biologists at the University...ete genetic blueprint of Dictyostelium discoideum,...s a model genetic system, much like fruit flies an...of human diseases. , The scientific details of th...h involved 97 scientists from 22 institutions in f...
...Belgium have discovered how to clone human embryos...y. Their discovery should make it easier for scien...ned embryos and develop them to provide eggs and s...ence of the European Society of Human Reproduction...til now, scientists investigating human cloning fo...
...ombarded by information about the physical proport...such as a puff of wind or the brush of our own shi... the body,s outer bounds, creating a sense of what...rchers report this week that the brain,s ability t...of bodily self is more dynamic than had been previ...
Other Biology News:Biologists determine genetic blueprint of social amoeba 2Biologists determine genetic blueprint of social amoeba 3Scientists succeed in cloning human embryos from eggs matured in the lab 2Scientists succeed in cloning human embryos from eggs matured in the lab 3To translate touch, the brain can quickly rearrange its sense of the body 2
Anti-Rat Dipeptidyl Peptidase IV (DPP IV) Monoclonal Antibody, Unconjugated, Clone 5E8 from Cell Sciences
Rabbit Anti-Human JAB1 Antibody, Unconjugated from ABR-Affinity BioReagents
Anti-gp64 Antibody, Unconjugated from Novagen
Rabbit Anti-Human SYT16 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Biology Products: